Novel cardiac myofilament desensitizing factor released by endocardial and vascular endothelial cells
- PMID: 8205654
- DOI: 10.1161/01.cir.89.6.2492
Novel cardiac myofilament desensitizing factor released by endocardial and vascular endothelial cells
Abstract
Background: Recent studies suggest that both endocardial endothelium and coronary vascular endothelium influence myocardial contraction, but the mediators responsible and their mechanisms of action are not well defined.
Methods and results: We investigated the effects of cultured endocardial endothelial and vascular endothelial cell superfusate on contraction and intracellular calcium transients of isolated rat cardiac myocytes. Endothelial cell superfusate induced a potent negative inotropic effect, with a rapid reversible decrease in myocyte twitch amplitude, earlier twitch relaxation, and a significant increase in diastolic length. This effect was not associated with significant changes in intracellular calcium or pH; was not attributable to nitric oxide, prostanoids, cGMP, or protein kinase C activation; and did not involve pertussis toxin-sensitive G proteins. The activity was stable at 37 degrees C for several hours, was not destroyed by protease treatment, and was found in low-molecular-weight (<< 1 kD) superfusate fractions.
Conclusions: These data suggest the tonic release by endothelial cells of a novel, stable factor that acts predominantly by reducing the response of cardiac myofilaments to calcium (ie, "desensitizes" them). This "desensitizing factor" could rapidly modulate cardiac contraction-relaxation coupling and diastolic tonus and exert distant effects because of its stability.
Similar articles
-
Paracrine effects of endocardial endothelial cells on myocyte contraction mediated via endothelin.Am J Physiol. 1993 Nov;265(5 Pt 2):H1841-6. doi: 10.1152/ajpheart.1993.265.5.H1841. Am J Physiol. 1993. PMID: 8238598
-
The cardiac endothelium: cardioactive mediators.Prog Cardiovasc Dis. 1996 Nov-Dec;39(3):263-84. doi: 10.1016/s0033-0620(96)80005-3. Prog Cardiovasc Dis. 1996. PMID: 8970577 Review.
-
Endothelial inhibition of myofilament calcium response in intact cardiac myocytes.Am J Physiol. 1995 Nov;269(5 Pt 2):H1538-44. doi: 10.1152/ajpheart.1995.269.5.H1538. Am J Physiol. 1995. PMID: 7503246
-
Inhibition of myocardial crossbridge cycling by hypoxic endothelial cells: a potential mechanism for matching oxygen supply and demand?Circ Res. 1997 May;80(5):688-98. doi: 10.1161/01.res.80.5.688. Circ Res. 1997. PMID: 9130450
-
Endothelial control of vascular and myocardial function in heart failure.Cardiovasc Drugs Ther. 1994 Jun;8(3):437-46. doi: 10.1007/BF00877920. Cardiovasc Drugs Ther. 1994. PMID: 7947359 Review.
Cited by
-
The Cardiomyocyte in Cirrhosis: Pathogenic Mechanisms Underlying Cirrhotic Cardiomyopathy.Rev Cardiovasc Med. 2024 Dec 24;25(12):457. doi: 10.31083/j.rcm2512457. eCollection 2024 Dec. Rev Cardiovasc Med. 2024. PMID: 39742234 Free PMC article. Review.
-
Molecular mechanisms in endothelial regulation of cardiac function.Mol Cell Biochem. 2003 Nov;253(1-2):113-23. doi: 10.1023/a:1026061507004. Mol Cell Biochem. 2003. PMID: 14619961 Review.
-
Clinical pharmacokinetics of vasodilators. Part I.Clin Pharmacokinet. 1998 Jun;34(6):457-82. doi: 10.2165/00003088-199834060-00003. Clin Pharmacokinet. 1998. PMID: 9646008 Review.
-
Endothelium, for example.J R Coll Physicians Lond. 1996 Jan-Feb;30(1):42-51. J R Coll Physicians Lond. 1996. PMID: 8745363 Free PMC article. Review.
-
Cardiac dysfunction in sepsis: new theories and clinical implications.Intensive Care Med. 1998 Apr;24(4):286-95. doi: 10.1007/s001340050570. Intensive Care Med. 1998. PMID: 9609405 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources